Every particle matters - identify visible and subvisible particles in your biologic and gene and cell therapy drug product
Every particle matters - Identify visible and subvisible particles in your biologic and gene and cell therapy drug product
Particles in the visible and subvisible size range can appear in (bio)pharmaceutical samples and drug products during all stages of development and even after market approval. The presence of particles can indicate an insufficient stability of the active pharmaceutical ingredient or issues with the production process and can negatively influence the safety and efficacy of the medicine.
In this webinar we will talk about tools and methods for particle identification and characterization in biologics and gene and cell therapy drug products.
- What type of particles can be present in a biologic or gene & cell therapy product?
- What needs to be characterized and how?
- Where can particle identification provide added value to your drug product development or troubleshooting?
The duration of this webinar is one hour and will include the ability to submit questions.
Speaker: Dr. Tim Menzen, Chief Technology Officer, and Dr. Daniel Demminger, Expert Scientist at Coriolis Pharma
Moderator: Dr. Daniel Weinbuch, Business Development Manager at Coriolis Pharma
Webinars will be available for unlimited on-demand viewing after live event.